FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

NCT02371031 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Funding source for study ended.

Conditions

Glioma
Malignant Glioma

Interventions

DRUG: 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine
DEVICE: PET/MRI
PROCEDURE: Surgical resection (standard of care)

Sponsor

Washington University School of Medicine